+254 (0) 798 725 500
[email protected]
Quality Policy
ISO 9001:2015 Certification
  • Home
  • About Us
    • Team
  • Services
    • Pharmacovigilance
      • Qualified Person for Pharmacovigilance (QPPV)
      • Pharmacovigilance system master file (PSMF) Services
      • Case management services
      • Periodic safety report management (PSRs)
      • Literature screening/monitoring
      • Pharmacovigilance audits and inspections
      • Pharmacovigilance Quality system
      • Signal detection and management
      • Pharmacovigilance Regulatory intelligence
      • Risk Management Plans (RMP)
      • Medical writing and Translations
      • Management of medical information call center (MICC)
    • Regulatory Affairs
    • Local Technical Representative
    • Pharma Market Research
    • Quality Assurance
    • Training
  • Resources
    • Case Studies
    • Our Blog
  • Contact us
    • Pharmaceutical Compliance Solutions – FAQS
Enquire
we are open from Monday to Friday 8:00 AM to 5:00 PM and are closed on Saturday and Sunday.

The Existing Need For Good Pharmacovigilance Practices

Posted on April 13, 2024

The Pharmacovigilance practice has been evolving over time. The need for pharmacovigilance practices can be traced back to the very first individual case reports of adverse drug reactions such as the Thalidomide cases. In recent years, pharmacovigilance reporting has evolved. The ever-growing need for pharmacovigilance has seen more stakeholders get on board.

They now include:

  •       Pharmacovigilance consulting companies that are contracted by pharmaceutical companies to offer pharmacovigilance services and consultation.
  •         Government reporting systems which are accessible to all members of the public.

The scope of business in pharmaceutics and life sciences in general has grown immensely. Equally, the need for safer and more effective pharma products has increased.1

This article provides insights into the existing need to build a good pharmacovigilance system in any life science company. It sheds light on the pharmacovigilance scope within which these companies should operate in order to ensure they are meeting market demand for safe and effective products.

Over time, Jeyflex Consultants has bridged the gap in good pharmacovigilance practices. Making sure that pharmaceutical products are safe and satisfy regulatory standards. 

Some of the components of good pharmacovigilance practices are:

COMMUNICATION

The focus of a pharmaceutical company regarding the risk management approach for a specific product is communication. Pharmaceutical businesses mainly use labelling tools, currently regulated based on templates such as those of the European Medicines Agency, to communicate product safety and risk.

These tools may also include the: Summary of Product Characteristics (SmPC), package insert, patient information leaflet (PIL), and secondary packaging.

It could be challenging to determine whether a company’s communication with patients, healthcare providers, or the general public is redundant or inefficient when using these communication tools. Pharmaceutical companies should establish a pharmacovigilance base. Its main responsibility should be organising the company’s communications strategy by predetermined goals with stakeholders, not merely regulatory bodies.

For each specific product that the corporation sells, this same group can evaluate the efficacy of the communications, track audience responses, and modify the marketing plan as necessary. An example would be the addition of an electronic support system for reporting adverse effects by a company apart from the one provided by the state.

AUDITS AND INSPECTIONS

By law, pharmaceutical organisations and businesses are subject to audits and inspections by the appropriate national and international regulatory agencies such as the European Medicines Agency and Health Canada.

The WHO (World Health Organization) auditing the PPB, the Kenyan pharmaceutical regulatory agency, is an excellent example of an international body auditing a local regulatory body. Pharmaceutical companies must carry out pharmacovigilance audits and inspection programs. These aid in both the execution of audits predicated on process risk assessment and the modification and enhancement of pharmacovigilance procedures.

Pharmacovigilance systems that can be enhanced by proper inspection programs include:

  •         Signal detection, management and recording
  •         Proper use of data mining tools and data source management

As a sound pharmacovigilance practice, audits also assist in maintaining the company’s compliance with medication safety standards and regulations. Conducting audits on pharmaceutical companies helps to assess compliance and guarantee patient safety.

The responsible Marketing Authorization Holders (MAH) of health products must keep records of post-authorization safety studies.

CONCLUSION

Considering the two tools mentioned above for good pharmacovigilance practices, our team at Jeyflex is committed to assisting pharmaceutical companies in implementing these practices through the development of data source management. We also have a team capable of carrying out the required self-audit in connection with good pharmacovigilance practices.

References

  1.       Deloitte, 2023. Life Sciences: Deloitte. [Online]
    Available at: https://www2.deloitte.com/cn/en/pages/life-sciences-and-healthcare/articles/global-life-sciences-sector-outlook-2023.html
    [Accessed 11 03 2024].
  2.     Agency, E. M., 2012. Guideline on good pharmacovigilance practices (GVP). [Online]
    Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-module-iv-pharmacovigilance-audits-superseded_en.pdf
    [Accessed 13 03 2024].

 

Article by Purity Wanjiku

Previous Post
Pharmacovigilance (PV) Outsourcing — New PV business models.
Next Post
Regulatory Affairs: New Drug Registration Process
Why Jeyflex?

Find all the pharmaceutical compliance services you need under one roof. With our Pan-African approach, you’ll only need one consultant for your full list of compliance needs. 

Services

Regulatory Affairs
Local Technical Representation (LTR)
Pharmacovigilance
Quality Assurance
Training
Pharma Market Research

Resources

Introduce new drug to Africa
State of pharmaceuticals in Africa
Pharma Data Africa
What you need to know
Blog
News

Company

Talk to us
Why we’re unique
Our Coverage
Case Studies
Our Leadership
FAQs

Reach Out
+254 798 725 500
[email protected]
Service enquiry

Copyright 2024 © Jeyflex Consultants Ltd | ISO 9001:2015 Certification| All Rights Reserved | Built by Digital 4 Africa

Sitemap | Terms of use | Privacy Policy

WhatsApp
Hello! 😊

Thank you for visiting the Jeyflex website.

We're here to assist you with all your pharmaceutical needs. 💊

Have questions? Need assistance? Just click the Let's chat icon to talk to Maggie! 🌟
Let's chat